| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
6,417 |
6,134 |
$526K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,992 |
7,485 |
$405K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,039 |
964 |
$205K |
| 93000 |
|
12,269 |
11,272 |
$139K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,257 |
2,074 |
$89K |
| 99233 |
Prolong inpt eval add15 m |
1,516 |
716 |
$80K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
965 |
919 |
$76K |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
6,501 |
6,232 |
$50K |
| 99222 |
Initial hospital care, per day, moderate complexity |
627 |
596 |
$44K |
| 93015 |
|
1,088 |
1,012 |
$44K |
| 93296 |
|
1,016 |
978 |
$14K |
| 93280 |
|
383 |
371 |
$12K |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
4,328 |
4,170 |
$11K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
526 |
508 |
$8K |
| G1007 |
Clinical decision support mechanism aim specialty health, as defined by the medicare appropriate use criteria program |
31 |
31 |
$6K |
| 93294 |
|
592 |
576 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
53 |
51 |
$4K |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
1,332 |
1,302 |
$4K |
| 93297 |
|
598 |
578 |
$3K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
108 |
77 |
$3K |
| 93970 |
|
17 |
13 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
255 |
213 |
$3K |
| 93880 |
|
15 |
14 |
$2K |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
5,955 |
5,739 |
$1K |
| 93299 |
|
117 |
102 |
$1K |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
2,720 |
2,636 |
$1K |
| 93224 |
|
12 |
12 |
$1K |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
3,383 |
3,268 |
$974.36 |
| 99221 |
|
26 |
26 |
$919.64 |
| 0296T |
|
97 |
94 |
$832.82 |
| 1123F |
|
4,526 |
4,368 |
$623.42 |
| 0298T |
|
147 |
141 |
$579.46 |
| 4086F |
|
3,595 |
3,480 |
$403.19 |
| J2785 |
Injection, regadenoson, 0.1 mg |
456 |
419 |
$249.48 |
| 1036F |
|
5,972 |
5,749 |
$188.65 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
855 |
837 |
$126.87 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
5,382 |
5,189 |
$44.12 |
| G8598 |
Aspirin or another antiplatelet therapy used |
2,449 |
2,383 |
$11.12 |
| 93248 |
|
12 |
12 |
$6.04 |
| G8599 |
Aspirin or another antiplatelet therapy not used, reason not given |
242 |
239 |
$0.30 |
| G9724 |
Patients who had documentation of use of anticoagulant medications overlapping the measurement year |
79 |
78 |
$0.00 |
| 4004F |
|
260 |
254 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
67 |
66 |
$0.00 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
1,005 |
925 |
$-5558.35 |